VYNE Therapeutics Inc.(VYNE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VYNE VYNE Therapeutics Inc.

休市中 05-24 16:00:00 EDT

2.58

-0.05

-1.90%

盘后2.58

+0.000.00%

17:28 EDT

最高2.65	最低2.51	成交量2.27万
今开2.65	昨收2.63	日振幅5.32%
总市值3,638万	流通市值2,438万	总股本1,410万
成交额5.91万	换手率0.24%	流通股本944.99万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"VYNE","market":"US","secType":"STK","nameCN":"VYNE Therapeutics Inc.","latestPrice":2.58,"timestamp":1716580800000,"preClose":2.63,"halted":0,"volume":22664,"hourTrading":{"tag":"盘后","latestPrice":2.58,"preClose":2.58,"latestTime":"17:28 EDT","volume":2,"amount":5.06,"timestamp":1716586095141},"delay":0,"floatShares":9449882,"shares":14098888,"eps":-1.4546,"marketStatus":"休市中","marketStatusCode":7,"change":-0.05,"latestTime":"05-24 16:00:00 EDT","open":2.65,"high":2.65,"low":2.51,"amount":59064.770519,"amplitude":0.053232,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.4546,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716883200000},"adr":0,"listingDate":1516856400000,"adjPreClose":2.63,"postHourTrading":{"tag":"盘后","latestPrice":2.58,"preClose":2.58,"latestTime":"17:28 EDT","volume":2,"amount":5.06,"timestamp":1716586095141},"volumeRatio":1.076360523976216},"requestUrl":"/m/hq/s/VYNE/","defaultTab":"news","newsList":[{"id":"2433738771","title":"Vyne Therapeutics Inc.盘中异动 下午盘股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433738771","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433738771?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:19","pubTimestamp":1715102353,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日01时19分，Vyne Therapeutics Inc.股票出现波动，股价快速上涨5.17%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.03%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。该信息摘要如下：HC Wainwright & Co.：重申VYNE Therapeutics评级，由买入调整至买入评级, 目标价5.75美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801191479264f85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801191479264f85&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433799482","title":"Vyne Therapeutics Inc    预计每股亏损 24 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433799482","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433799482?lang=zh_cn&edition=full","pubTime":"2024-05-07 19:01","pubTimestamp":1715079710,"startTime":"0","endTime":"0","summary":"   * Vyne Therapeutics Inc    预计将在5月9日公布截至0001年1月1日的业绩报告(估计)，季度收入将有所增长。* LSEG 分析师对 Vyne Therapeutics Inc 的平均预期是每股亏损 24 美分。* 华尔街对 Vyne Therapeutics Inc 的 12 个月目标价中位数为 5.75 美元，高于其最新收盘价 2.71 美元。5月7日 - 本摘要于北京时间 5 月 7 日 11:01 机器生成。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433745408","title":"HC Wainwright & Co.：重申VYNE Therapeutics(VYNE.US)评级，由买入调整至买入评级, 目标价5.75美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433745408","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433745408?lang=zh_cn&edition=full","pubTime":"2024-05-06 22:55","pubTimestamp":1715007355,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申VYNE Therapeutics(VYNE.US)评级，由买入调整至买入评级, 目标价5.75美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405062256018ae192a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405062256018ae192a2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426447885","title":"Vyne Therapeutics Inc.盘中异动 股价大跌7.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426447885","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426447885?lang=zh_cn&edition=full","pubTime":"2024-04-11 03:41","pubTimestamp":1712778118,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日03时41分，Vyne Therapeutics Inc.股票出现波动，股价快速跳水7.61%。截至发稿，该股报2.55美元/股，成交量5.1016万股，换手率0.36%，振幅5.07%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.89%。其相关个股中，Adial Pharmaceuticals, Inc、Jaguar Health, Inc.、Alpine Immune Sciences, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为2390.46%、105.62%、95.88%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Orgenesis Inc.、Nutriband Inc C/Wts ，振幅分别为87.61%、78.35%、52.44%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411034159861e4baf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411034159861e4baf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422822616","title":"Vyne Therapeutics Inc.盘中异动 大幅上涨5.24%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422822616","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422822616?lang=zh_cn&edition=full","pubTime":"2024-03-26 21:50","pubTimestamp":1711461030,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日21时50分，Vyne Therapeutics Inc.股票出现波动，股价大幅拉升5.24%。截至发稿，该股报2.60美元/股，成交量1.1239万股，换手率0.08%，振幅8.06%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326215031861e1418&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326215031861e1418&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421078658","title":"Vyne Therapeutics Inc.盘中异动 下午盘快速上涨5.05%报2.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421078658","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421078658?lang=zh_cn&edition=full","pubTime":"2024-03-22 02:33","pubTimestamp":1711045996,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日02时33分，Vyne Therapeutics Inc.股票出现波动，股价大幅拉升5.05%。截至发稿，该股报2.29美元/股，成交量2.8288万股，换手率0.20%，振幅6.33%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.04%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322023316861e02c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322023316861e02c4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420275275","title":"Vyne Therapeutics Inc.盘中异动 大幅上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420275275","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420275275?lang=zh_cn&edition=full","pubTime":"2024-03-19 22:34","pubTimestamp":1710858867,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日22时34分，Vyne Therapeutics Inc.股票出现异动，股价急速拉升5.19%。截至发稿，该股报2.02美元/股，成交量3461股，换手率0.02%，振幅5.99%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031922342787e7a178&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031922342787e7a178&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417247233","title":"Vyne Therapeutics Inc.盘中异动 快速上涨5.78%报2.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417247233","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417247233?lang=zh_cn&edition=full","pubTime":"2024-03-07 05:00","pubTimestamp":1709758821,"startTime":"0","endTime":"0","summary":"北京时间2024年03月07日05时00分，Vyne Therapeutics Inc.股票出现波动，股价快速上涨5.78%。截至发稿，该股报2.38美元/股，成交量9.4395万股，换手率0.67%，振幅6.67%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240307050022861dbe44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240307050022861dbe44&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416679120","title":"Vyne Therapeutics Inc.盘中异动 临近收盘股价大跌5.38%报2.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416679120","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416679120?lang=zh_cn&edition=full","pubTime":"2024-03-02 04:43","pubTimestamp":1709325803,"startTime":"0","endTime":"0","summary":"北京时间2024年03月02日04时43分，Vyne Therapeutics Inc.股票出现波动，股价大幅跳水5.38%。截至发稿，该股报2.11美元/股，成交量7.962万股，换手率0.57%，振幅5.83%。Vyne Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为2.64%。Vyne Therapeutics Inc.公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030204432387e7552d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030204432387e7552d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414836928","title":"Vyne Therapeutics Inc盘中异动 快速上涨6.19%报2.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414836928","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414836928?lang=zh_cn&edition=full","pubTime":"2024-02-26 23:21","pubTimestamp":1708960904,"startTime":"0","endTime":"0","summary":"北京时间2024年02月26日23时21分，Vyne Therapeutics Inc股票出现波动，股价急速拉升6.19%。Vyne Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Zyversa Therapeutics Inc、Krystal Biotech Inc、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Zyversa Therapeutics Inc、Lixte Biotechnology Holdings  Inc、Ocean Biomedical Inc较为活跃，换手率分别为1340.15%、61.67%、56.17%，振幅较大的相关个股有Zyversa Therapeutics Inc、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Ocean Biomedical Inc，振幅分别为144.82%、62.88%、52.23%。Vyne Therapeutics Inc公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022623214487e732c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022623214487e732c7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413876435","title":"Vyne Therapeutics Inc盘中异动 早盘急速上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413876435","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413876435?lang=zh_cn&edition=full","pubTime":"2024-02-23 22:30","pubTimestamp":1708698623,"startTime":"0","endTime":"0","summary":"北京时间2024年02月23日22时30分，Vyne Therapeutics Inc股票出现异动，股价快速上涨5.07%。Vyne Therapeutics Inc股票所在的生物技术行业中，整体涨幅为1.96%。其相关个股中，Ocean Biomedical Inc、Maravai Lifesciences Hldgs Inc、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大，Enveric Biosciences Inc、Biodexa Pharmaceuticals Plc、Clearmind Medicine Inc较为活跃，换手率分别为248.71%、96.08%、92.56%，振幅较大的相关个股有Maravai Lifesciences Hldgs Inc、Ocean Biomedical Inc、Maia Biotechnology Inc，振幅分别为5.37%、4.55%、4.08%。Vyne Therapeutics Inc公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402232230247913eb83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402232230247913eb83&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411089393","title":"Vyne Therapeutics Inc盘中异动 下午盘快速下挫5.31%报1.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411089393","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411089393?lang=zh_cn&edition=full","pubTime":"2024-02-14 02:34","pubTimestamp":1707849243,"startTime":"0","endTime":"0","summary":"北京时间2024年02月14日02时34分，Vyne Therapeutics Inc股票出现异动，股价大幅跳水5.31%。截至发稿，该股报1.96美元/股，成交量3.2138万股，换手率0.23%，振幅5.31%。Vyne Therapeutics Inc股票所在的生物技术行业中，整体跌幅为1.06%。Vyne Therapeutics Inc公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021402340387e6ff31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021402340387e6ff31&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2408560944","title":"Vyne Therapeutics Inc盘中异动 下午盘快速下挫5.03%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2408560944","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2408560944?lang=zh_cn&edition=full","pubTime":"2024-02-01 03:06","pubTimestamp":1706728005,"startTime":"0","endTime":"0","summary":"北京时间2024年02月01日03时06分，Vyne Therapeutics Inc股票出现异动，股价快速下跌5.03%。截至发稿，该股报1.70美元/股，成交量5.8925万股，换手率0.42%，振幅5.43%。Vyne Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.29%。Vyne Therapeutics Inc公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240201030646790de8c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240201030646790de8c2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2406421652","title":"Vyne Therapeutics Inc盘中异动 快速下挫6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2406421652","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2406421652?lang=zh_cn&edition=full","pubTime":"2024-01-25 01:20","pubTimestamp":1706116836,"startTime":"0","endTime":"0","summary":"北京时间2024年01月25日01时20分，Vyne Therapeutics Inc股票出现异动，股价急速下挫6.02%。截至发稿，该股报1.80美元/股，成交量1.1796万股，换手率0.08%，振幅5.76%。Vyne Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.68%。Vyne Therapeutics Inc公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240125012036790bd216&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240125012036790bd216&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402472183","title":"Vyne Therapeutics Inc盘中异动 早盘股价大跌5.36%报2.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2402472183","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402472183?lang=zh_cn&edition=full","pubTime":"2024-01-12 00:05","pubTimestamp":1704989120,"startTime":"0","endTime":"0","summary":"北京时间2024年01月12日00时05分，Vyne Therapeutics Inc股票出现异动，股价快速跳水5.36%。截至发稿，该股报2.12美元/股，成交量1.5978万股，换手率0.11%，振幅6.37%。Vyne Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.42%。Vyne Therapeutics Inc公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240112000520790826d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240112000520790826d4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2401671950","title":"Vyne Therapeutics Inc盘中异动 早盘快速下跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2401671950","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2401671950?lang=zh_cn&edition=full","pubTime":"2024-01-08 22:48","pubTimestamp":1704725310,"startTime":"0","endTime":"0","summary":"北京时间2024年01月08日22时48分，Vyne Therapeutics Inc股票出现异动，股价大幅下跌5.56%。Vyne Therapeutics Inc股票所在的生物技术行业中，整体跌幅为1.38%。其相关个股中，Harpoon Therapeutics Inc、Ambrx Biopharma Inc 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Cyclacel Pharmaceuticals Inc、Cellectar Biosciences Inc、Vincerx Pharma Inc较为活跃，换手率分别为279.46%、80.39%、78.61%，振幅较大的相关个股有Biocardia Inc C/Wts 06/08/2024、Effector Therapeutics Inc C/Wts 31/12/2025 、Vincerx Pharma Inc，振幅分别为59.00%、29.73%、25.42%。Vyne Therapeutics Inc公司简介：VYNE Therapeutics Inc 是一家生物制药公司，专注于开发专有的、创新的和差异化的治疗免疫炎症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240108224830861c9294&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240108224830861c9294&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vynetherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0686},{"period":"1month","weight":0.0039},{"period":"3month","weight":0.1416},{"period":"6month","weight":-0.3566},{"period":"1year","weight":-0.6346},{"period":"ytd","weight":0.1073}],"compareEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.0475},{"period":"3month","weight":0.0425},{"period":"6month","weight":0.1628},{"period":"1year","weight":0.2768},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"VYNE Therapeutics Inc.成立于2011年10月，是特拉华州的一家公司，名称为Tigercat Pharma，Inc.。该公司是一家专业制药公司，致力于开发和商业化专有疗法，以满足皮肤病学未满足的需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.103241},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.000108},{"month":3,"riseRate":0.428571,"avgChangeRate":0.048397},{"month":4,"riseRate":0.142857,"avgChangeRate":-0.184881},{"month":5,"riseRate":0.571429,"avgChangeRate":0.040296},{"month":6,"riseRate":0,"avgChangeRate":-0.153492},{"month":7,"riseRate":0.5,"avgChangeRate":-0.069543},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.086697},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.043905},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.070084},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.067878},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.145707}],"exchange":"NASDAQ","name":"VYNE Therapeutics Inc.","nameEN":"VYNE Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"VYNE Therapeutics Inc.(VYNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供VYNE Therapeutics Inc.(VYNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"VYNE Therapeutics Inc.,VYNE,VYNE Therapeutics Inc.股票,VYNE Therapeutics Inc.股票老虎,VYNE Therapeutics Inc.股票老虎国际,VYNE Therapeutics Inc.行情,VYNE Therapeutics Inc.股票行情,VYNE Therapeutics Inc.股价,VYNE Therapeutics Inc.股市,VYNE Therapeutics Inc.股票价格,VYNE Therapeutics Inc.股票交易,VYNE Therapeutics Inc.股票购买,VYNE Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"VYNE Therapeutics Inc.(VYNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供VYNE Therapeutics Inc.(VYNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}